Relapse prevention (RP) TMS

Saxby Pridmore; Tamara May

doi:10.1016/j.brs.2018.08.004

Relapse prevention (RP) TMS

Brain Stimul. 2018 Nov-Dec;11(6):1391-1392. doi: 10.1016/j.brs.2018.08.004. Epub 2018 Aug 16.

Authors

Saxby Pridmore¹, Tamara May²

Affiliations

¹ School of Medicine, University of Tasmania, Hobart, Tasmania, Australia; TMS Department, Saint Helen's Hospital, Hobart, Tasmania, Australia. Electronic address: s.pridmore@utas.edu.au.
² School of Psychology, Deakin University, Burwood, Victoria, Australia. Electronic address: tamara.may@deakin.edu.au.

PMID: 30143418
DOI: 10.1016/j.brs.2018.08.004

Abstract

Background: TMS is safe and effective in the treatment of MDD, but as with other treatments, relapse may occur on cessation of treatment.

Objective: To prevent relapse in MDD, following successful acute TMS treatment.

Method: 5 TMS treatments over 3 days, repeated at about monthly intervals.

Results: 14 patients received this care for more than 12 months. At the commencement of each series the mood scores were close to relapse, but at completion they were in the remitted range.

Conclusion: Such treatment is useful. It is better conceptualized as relapse prevention rather than remittance maintenance.

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Depressive Disorder, Major / diagnosis
Depressive Disorder, Major / psychology*
Depressive Disorder, Major / therapy*
Female
Humans
Male
Middle Aged
Recurrence
Secondary Prevention / methods
Time Factors
Transcranial Magnetic Stimulation / methods*
Treatment Outcome